EVIDENCE LIBRARY
What a Fentanyl Test Strip Can and Cannot Establish
A published five-lot study shows why fentanyl test-strip results depend on lot, analog, interference, dilution, and the limits of a negative response.
Fentanyl test strips can provide useful harm-reduction screening information. A strip result is not a complete chemical analysis of an unknown mixture. Its meaning depends on the particular product, manufacturing lot, sample preparation, target concentration, fentanyl analog, potential interferents, and how the visual result was read.
A 2024 laboratory study by Halifax and colleagues examined five manufacturing lots of one widely distributed fentanyl test strip. The findings support both sides of a careful interpretation: the strips detected fentanyl and the tested analogs under the study conditions, while sensitivity and interference behavior varied across lots.
The study evaluated one product under controlled conditions
The researchers tested five lots of the BTNX Rapid Response lateral-flow strip with a stated 20 nanogram-per-milliliter urine cutoff. Drug standards were dissolved in water and serially diluted. The team evaluated fentanyl, selected fentanyl analogs, and possible interfering compounds.
That design provides controlled comparisons. It does not reproduce every street-drug mixture, solvent, concentration, particle distribution, or field-reading condition. Results from these five lots should not be assigned automatically to another manufacturer, another strip design, or later production.
Lot-to-lot performance was not constant
All five lots reacted with fentanyl and the eleven fentanyl analogs evaluated in the study. The concentration at which responses appeared, however, varied by lot and compound. The authors reported meaningful differences between older and newer lots, including reduced sensitivity for fentanyl and some analogs in the tested 2021 lots.
This means a brand name and nominal cutoff do not fully describe performance. A defensible review should identify the lot number, expiration date, storage history, instructions in effect at the time, and any independent performance testing for that production lot.
Interferents can create positive strip responses
The study reported false-positive responses from diphenhydramine, lidocaine, MDMA, and methamphetamine at tested concentrations. The response thresholds and affected lots were not identical. That variability is important because an instruction designed around one lot may not produce the same balance of sensitivity and interference with another.
The presence of one of these compounds does not prove that it caused a particular result. A case-specific interpretation requires the actual mixture composition, concentration after preparation, strip lot, procedure, timing, photographs, and any confirmatory testing.
Dilution creates competing analytical risks
Dilution may reduce a high-concentration interference response. Greater dilution can also move fentanyl or an analog below the strip’s effective detection level. The paper therefore describes a practical tension between reducing false-positive responses and avoiding false-negative responses.
There is no single dilution statement in this study that can guarantee accurate performance for every mixture. This article does not provide individualized drug-use or sample-preparation instructions. The analytical lesson is that a result cannot be interpreted without knowing how the sample was prepared and which lot was used.
A negative strip does not establish safety
A negative response means that the prepared sample did not trigger the particular strip’s positive decision rule under the conditions used. It does not establish that the original material contained no fentanyl, that every portion of a heterogeneous mixture was represented, that every fentanyl analog was detectable, or that the substance was safe.
Powders and counterfeit tablets can be uneven mixtures. Testing one small portion may not represent another portion. Fentanyl test strips also do not provide a complete inventory of other potent opioids, adulterants, or pharmacologically active substances.
The site’s broader Fentanyl and Analog Analysis guide explains why targeted analytical methods may miss new or uncommon compounds. The same method-bound reasoning applies here: a result should not be extended beyond the strip’s demonstrated target range and operating conditions.
Records needed to evaluate a strip result
- Manufacturer, exact strip product, lot number, expiration date, and storage history.
- Instructions supplied with that lot and any later safety or performance notice.
- Original material description, packaging, appearance, and evidence of mixture heterogeneity.
- The portion selected, quantity, solvent, dilution, mixing, timing, temperature, and container.
- Photographs of the strip at the specified reading time, including control and test lines.
- The identity and training of the person performing and reading the test.
- All positive, negative, invalid, repeated, or conflicting results.
- Independent laboratory results identifying fentanyl, analogs, interferents, and other constituents.
- Method validation, detection capability, cross-reactivity, and quality-control information.
These records place the observation within the broader question of analytical selectivity rather than treating a line on a strip as a complete identification.
The defensible conclusion is limited
The Halifax study supports fentanyl test strips as an important harm-reduction tool while documenting product-lot and interference limitations. A positive strip can support a warning that fentanyl or a cross-reacting substance may be present. A negative strip cannot prove absence or safety.
For forensic or public-health review, the conclusion should identify the exact strip, lot, preparation, visual result, known limitations, and any laboratory confirmation. The test is most useful when its screening role is described accurately.
Source
Halifax JC, Lim L, Ciccarone D, Lynch KL. Testing the test strips: laboratory performance of fentanyl test strips. Harm Reduction Journal. 2024;21:14. Version-of-record DOI.
Safety boundary
Fentanyl test strips do not make drug use safe and do not replace emergency medical care. This page provides scientific information about analytical interpretation, not instructions for consuming or preparing drugs.